.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
AstraZeneca
Dow
QuintilesIMS
Johnson and Johnson
Moodys
Deloitte
Merck
Colorcon
Argus Health

Generated: September 20, 2017

DrugPatentWatch Database Preview

MERIDIA Drug Profile

« Back to Dashboard

Which patents cover Meridia, and when can generic versions of Meridia launch?

Meridia is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in MERIDIA is sibutramine hydrochloride. There are six drug master file entries for this compound. Additional details are available on the sibutramine hydrochloride profile page.

Summary for Tradename: MERIDIA

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list103
Clinical Trials: see list13
Patent Applications: see list5,610
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MERIDIA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-001Nov 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-002Nov 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-003Nov 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MERIDIA

Paragraph IV activity for: MERIDIA

Drugname Dosage Strength RLD Submissiondate
sibutramine hydrochlorideCapsules10 mg and 15 mgMeridia8/14/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cipla
Moodys
Fish and Richardson
Cerilliant
US Department of Justice
US Army
Deloitte
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot